{"id":"NCT00853970","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2009-09","completion":"2009-12","firstPosted":"2009-03-02","resultsPosted":"2011-01-26","lastUpdate":"2013-01-25"},"enrollment":299,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Inflammation"],"interventions":[{"type":"DRUG","name":"Bromfenac Ophthalmic Solution","otherNames":[]},{"type":"DRUG","name":"Placebo Comparator","otherNames":[]}],"arms":[{"label":"Bromfenac ophthalmic solution 0.09%","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery","primaryOutcome":{"measure":"Summed Ocular Inflammation Score (SOIS) of Zero","timeFrame":"Day 15 (Primary Endpoint)","effectByArm":[{"arm":"Bromfenac Ophthalmic Solution 0.09%","deltaMin":70,"sd":null},{"arm":"Placebo","deltaMin":36,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21751945"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":147},"commonTop":["Eye Pain","Foreign body sensation","Photophobia","Eye Inflammation","Blurred Vision"]}}